ID   NFIL3_RAT               Reviewed;         462 AA.
AC   Q6IMZ0; Q923M2;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   29-MAY-2024, entry version 135.
DE   RecName: Full=Nuclear factor interleukin-3-regulated protein;
DE   AltName: Full=E4 promoter-binding protein 4;
GN   Name=Nfil3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11262393; DOI=10.1074/jbc.m010332200;
RA   Nishimura Y., Tanaka T.;
RT   "Calcium-dependent activation of nuclear factor regulated by interleukin
RT   3/adenovirus E4 promoter-binding protein gene expression by
RT   calcineurin/nuclear factor of activated T cells and calcium/calmodulin-
RT   dependent protein kinase signaling.";
RL   J. Biol. Chem. 276:19921-19928(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Acts as a transcriptional regulator that recognizes and binds
CC       to the sequence 5'-[GA]TTA[CT]GTAA[CT]-3', a sequence present in many
CC       cellular and viral promoters. Represses transcription from promoters
CC       with activating transcription factor (ATF) sites. Represses promoter
CC       activity in osteoblasts. Represses transcriptional activity of PER1.
CC       Represses transcriptional activity of PER2 via the B-site on the
CC       promoter. Activates transcription from the interleukin-3 promoter in T-
CC       cells. Competes for the same consensus-binding site with PAR DNA-
CC       binding factors (DBP, HLF and TEF). Component of the circadian clock
CC       that acts as a negative regulator for the circadian expression of PER2
CC       oscillation in the cell-autonomous core clock. Protects pro-B cells
CC       from programmed cell death (By similarity). Represses the transcription
CC       of CYP2A5 (By similarity). Positively regulates the expression and
CC       activity of CES2 by antagonizing the repressive action of NR1D1 on CES2
CC       (By similarity). Required for the development of natural killer cell
CC       precursors (By similarity). {ECO:0000250|UniProtKB:O08750,
CC       ECO:0000250|UniProtKB:Q16649}.
CC   -!- SUBUNIT: Homodimer (By similarity). Binds DNA as a dimer (By
CC       similarity). Interacts with CRY2, DR1 and PER2 (By similarity).
CC       Interacts with NR0B2 (By similarity). Interacts with MYSM1 (By
CC       similarity). {ECO:0000250|UniProtKB:O08750,
CC       ECO:0000250|UniProtKB:Q16649}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00978}.
CC   -!- INDUCTION: Up-regulated by dexamethasone and thapsigargin.
CC       {ECO:0000269|PubMed:11262393}.
CC   -!- SIMILARITY: Belongs to the bZIP family. NFIL3 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY004663; AAF86615.1; -; mRNA.
DR   EMBL; BC072527; AAH72527.1; -; mRNA.
DR   RefSeq; NP_446179.2; NM_053727.2.
DR   RefSeq; XP_006253729.1; XM_006253667.3.
DR   RefSeq; XP_006253731.1; XM_006253669.2.
DR   RefSeq; XP_006253732.1; XM_006253670.3.
DR   AlphaFoldDB; Q6IMZ0; -.
DR   SMR; Q6IMZ0; -.
DR   STRING; 10116.ENSRNOP00000015525; -.
DR   iPTMnet; Q6IMZ0; -.
DR   PhosphoSitePlus; Q6IMZ0; -.
DR   PaxDb; 10116-ENSRNOP00000015525; -.
DR   Ensembl; ENSRNOT00000015525.7; ENSRNOP00000015525.3; ENSRNOG00000011668.7.
DR   Ensembl; ENSRNOT00000096237.1; ENSRNOP00000093138.1; ENSRNOG00000011668.7.
DR   Ensembl; ENSRNOT00000096697.1; ENSRNOP00000090522.1; ENSRNOG00000011668.7.
DR   Ensembl; ENSRNOT00000112357.1; ENSRNOP00000089110.1; ENSRNOG00000011668.7.
DR   Ensembl; ENSRNOT00055026598; ENSRNOP00055021572; ENSRNOG00055015605.
DR   Ensembl; ENSRNOT00055026602; ENSRNOP00055021575; ENSRNOG00055015605.
DR   Ensembl; ENSRNOT00055026606; ENSRNOP00055021578; ENSRNOG00055015605.
DR   Ensembl; ENSRNOT00055026610; ENSRNOP00055021581; ENSRNOG00055015605.
DR   Ensembl; ENSRNOT00060030501; ENSRNOP00060024654; ENSRNOG00060017820.
DR   Ensembl; ENSRNOT00060030518; ENSRNOP00060024672; ENSRNOG00060017820.
DR   Ensembl; ENSRNOT00060030539; ENSRNOP00060024693; ENSRNOG00060017820.
DR   Ensembl; ENSRNOT00060030540; ENSRNOP00060024694; ENSRNOG00060017820.
DR   Ensembl; ENSRNOT00065016083; ENSRNOP00065012180; ENSRNOG00065010003.
DR   Ensembl; ENSRNOT00065016084; ENSRNOP00065012181; ENSRNOG00065010003.
DR   Ensembl; ENSRNOT00065016087; ENSRNOP00065012186; ENSRNOG00065010003.
DR   Ensembl; ENSRNOT00065016090; ENSRNOP00065012187; ENSRNOG00065010003.
DR   GeneID; 114519; -.
DR   KEGG; rno:114519; -.
DR   AGR; RGD:620972; -.
DR   CTD; 4783; -.
DR   RGD; 620972; Nfil3.
DR   eggNOG; KOG3119; Eukaryota.
DR   GeneTree; ENSGT00940000160540; -.
DR   HOGENOM; CLU_052045_0_0_1; -.
DR   InParanoid; Q6IMZ0; -.
DR   OMA; PVDMTSK; -.
DR   OrthoDB; 4467729at2759; -.
DR   PhylomeDB; Q6IMZ0; -.
DR   TreeFam; TF328374; -.
DR   PRO; PR:Q6IMZ0; -.
DR   Proteomes; UP000002494; Chromosome 17.
DR   Bgee; ENSRNOG00000011668; Expressed in liver and 18 other cell types or tissues.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:RGD.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0071353; P:cellular response to interleukin-4; ISO:RGD.
DR   GO; GO:0007623; P:circadian rhythm; IBA:GO_Central.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0001779; P:natural killer cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IBA:GO_Central.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:InterPro.
DR   CDD; cd14694; bZIP_NFIL3; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR046347; bZIP_sf.
DR   InterPro; IPR047229; NFIL3-like.
DR   InterPro; IPR047106; NFIL3-like_bZIP.
DR   InterPro; IPR016743; NFIL3/E4BP4.
DR   InterPro; IPR010533; Vert_IL3-reg_TF.
DR   PANTHER; PTHR15284; NUCLEAR FACTOR INTERLEUKIN-3-REGULATED PROTEIN; 1.
DR   PANTHER; PTHR15284:SF1; NUCLEAR FACTOR INTERLEUKIN-3-REGULATED PROTEIN; 1.
DR   Pfam; PF07716; bZIP_2; 1.
DR   Pfam; PF06529; Vert_IL3-reg_TF; 1.
DR   PIRSF; PIRSF019029; bZIP_E4BP4; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF57959; Leucine zipper domain; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
PE   2: Evidence at transcript level;
KW   Activator; Biological rhythms; DNA-binding; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..462
FT                   /note="Nuclear factor interleukin-3-regulated protein"
FT                   /id="PRO_0000292669"
FT   DOMAIN          73..136
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          79..95
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          99..106
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          188..214
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          259..298
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        188..207
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        259..276
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        280..294
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         301
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   MOD_RES         353
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        24
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        214
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        219
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        219
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        314
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        326
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        332
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        337
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        350
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        360
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        401
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        406
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        412
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        419
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        424
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        434
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CROSSLNK        448
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16649"
FT   CONFLICT        45
FT                   /note="L -> P (in Ref. 1; AAF86615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        144
FT                   /note="S -> P (in Ref. 1; AAF86615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        270
FT                   /note="N -> S (in Ref. 1; AAF86615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        355
FT                   /note="A -> V (in Ref. 1; AAF86615)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   462 AA;  50781 MW;  1D7365C2F4B017EF CRC64;
     MQLRKMQAIK KEPASLDPTG SSDKMLLLNS ALAEVAEDLA SGEDLLLNEG SMGKNKSSAC
     RRKREFIPDE KKDAMYWEKR RKNNEAAKRS REKRRLNDLV LENKLIALGE ENATLKAELL
     SLKLKFGLIS STVYAQEIQK LSNSTAVYFQ DYQTSKAAVS SYVDEHEPAM VAGSCISVIK
     HSPQSSLSDV SEVSSVEHTQ ESPAQGGCRS PENKFPVIKQ EPVELESFAR ESREERGAYS
     ASIYQSYMGS SFSTYSHSPP LLQVHGSTSN SPRTSEADEG VVGKSSDGED EQQVPKGPIH
     SPVELQRVHA TVVKVPEVNP SALPHKLRIK AKAMQVKVEA LDSEFEGMQK LSSPADALAK
     RHFDLEKHGA SGTAHSSLPP FSVQVTNIQD WSLRSEHWHH KELGGKTQGT FKTGVVEVKD
     SGYKVSEAEN LYLKQGVANL SAEVVSLKRF IATQPISASD SR
//
